A Review on Nanotechnology in Cancer Diagnosis and Therapy: it’s Application
DOI:
https://doi.org/10.22270/ijmspr.v8i4.50Keywords:
Selected:Nanomaterials, Nanotechnology, Cancer, Diagnosis, TreatmentAbstract
Cancer is a leading cause of death and poor quality of life globally. Even though several strategies are devised to reduce deaths, reduce chronic pain and improve the quality of life, there remains a shortfall in the adequacies of these cancer therapies. Among the cardinal steps towards ensuring optimal cancer treatment are early detection of cancer cells and drug application with high specificity to reduce toxicities. Due to increased systemic toxicities and refractoriness with conventional cancer diagnostic and therapeutic tools, other strategies including nanotechnology are being employed to improve diagnosis and mitigate disease severity. Over the years, immunotherapeutic agents based on nanotechnology have been used for several cancer types to reduce the invasiveness of cancerous cells while sparing healthy cells at the target site. Nanomaterials including carbon nanotubes, polymeric micelles and liposomes have been used in cancer drug design where they have shown considerable pharmacokinetic and pharmacodynamic benefits in cancer diagnosis and treatment. In this review, we outline the commonly used nanomaterials which are employed in cancer diagnosis and therapy. We have highlighted the suitability of these nanomaterials for cancer management based on their physicochemical and biological properties. We further reviewed the challenges that are associated with the various nanomaterials which limit their uses and hamper their translatability into the clinical setting in certain cancer types.
Keywords: Nanomaterials, Nanotechnology, Cancer, Diagnosis, Treatment.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; 68: 394-424. https://doi.org/10.3322/caac.21492
Hu J, Huang W, Huang S, ZhuGe Q, Jin K, Zhao Y. Magnetically active Fe3O4 nanorods loaded with tissue plasminogen activator for enhanced thrombolysis. Nano Research. 2016; 9: 2652-61. https://doi.org/10.1007/s12274-016-1152-4
Huang L, Hu J, Huang S, Wang B, Siaw-Debrah F, Nyanzu M, Zhang Y, Zhuge Q. Nanomaterial applications for neurological diseases and central nervous system injury. Progress in Neurobiology. 2017; 157:29-48. https://doi.org/10.1016/j.pneurobio.2017.07.003
Tran S, DeGiovanni PJ, Piel B, Rai P. Cancer nanomedicine: a review of recent success in drug delivery. Clinical and Translational Medicine. 2017; 6(1):1-21. https://doi.org/10.1186/s40169-017-0175-0
Huang D, Wu K, Zhang Y, Ni Z, Zhu X, Zhu C, Yang J, ZhuGe Q, Hu J. Recent advances in tissue plasminogen activator-based nanothrombolysis for ischemic stroke. Reviews on Advanced Materials Science. 2019; 58(1):159-70. https://doi.org/10.1515/rams-2019-0024
Hu J, Huang S, Zhu L, Huang W, Zhao Y, Jin K, ZhuGe Q. Tissue plasminogen activator-porous magnetic microrods for targeted thrombolytic therapy after ischemic stroke. ACS Applied Materials & Interfaces. 2018; 10(39):32988-97. https://doi.org/10.1021/acsami.8b09423
Chaturvedi VK, Singh A, Singh VK, Singh MP. Cancer nanotechnology: a new revolution for cancer diagnosis and therapy. Current Drug Metabolism. 2019; 20: 416-29. https://doi.org/10.2174/1389200219666180918111528
Ye F, Zhao Y, El-Sayed R, Muhammed M, Hassan M. Advances in nanotechnology for cancer biomarkers. Nano Today. 2018; 18:103-23. https://doi.org/10.1016/j.nantod.2017.12.008
Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacology & Therapeutics. 2010; 128: 324-35 https://doi.org/10.1016/j.pharmthera.2010.07.007
Jain S, Purohit A, Nema P, Vishwakarma H, Jain PK. Intelligent or smart polymers: advance in novel drug delivery. Journal of Drug Delivery and Therapeutics. 2022; 12(5): 208-216. https://doi.org/10.22270/jddt.v12i5.5578
Jain S, Kirar M, Bindeliya M, Sen L, Soni M, Shan M, Purohit A, Jain PK, Novel drug delivery systems: an overview. Asian Journal of Dental and Health Sciences. 2022; 2(1):33-39.
Kim D, Jeong YY, Jon S. A drug-loaded aptamer− gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano. 2010; 4(7):3689-96. https://doi.org/10.1021/nn901877h
Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, et al. Nanomedicines as cancer therapeutics: current status. Current Cancer Drug Targets. 2013; 13: 362-78. https://doi.org/10.2174/1568009611313040002
Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Current Drug Metabolism. 2010; 11: 129-41 https://doi.org/10.2174/138920010791110827
Das PM, Bast RC, Jr. Early detection of ovarian cancer. Biomarkers in Medicine. 2008; 2: 291-303. https://doi.org/10.2217/17520363.2.3.291
Kuk C, Kulasingam V, Gunawardana CG, Smith CR, Batruch I, Diamandis EP. Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Molecular and Cellular Proteomics. 2009; 8: 661-9. https://doi.org/10.1074/mcp.M800313-MCP200
Fredolini C, Meani F, Luchini A, Zhou W, Russo P, Ross M, et al. Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. AAPS Journal. 2010; 12: 504-18. https://doi.org/10.1208/s12248-010-9211-3
Di Michele M, Marcone S, Cicchillitti L, Della Corte A, Ferlini C, Scambia G, et al. Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: towards the identification of putative biomarkers. Journal of Proteomics. 2010; 73: 879-98. https://doi.org/10.1016/j.jprot.2009.11.012
Jain S, Purohit A, Nema P, Vishwakarma H, Jain PK. A brief review on nutraceuticals and its application. Asian Journal of Dental and Health Sciences.2022; 2(1): 7-13.
Geho DH, Liotta LA, Petricoin EF, Zhao W, Araujo RP. The amplified peptidome: the new treasure chest of candidate biomarkers. Current Opinion in Chemical Biology. 2006; 10(1):50-5. https://doi.org/10.1016/j.cbpa.2006.01.008
Zhou M, Lucas DA, Chan KC, Issaq HJ, Petricoin EF, 3rd, Liotta LA, et al. An investigation into the human serum "interactome". Electrophoresis. 2004; 25: 1289-98. https://doi.org/10.1002/elps.200405866
Merrell K, Southwick K, Graves SW, Esplin MS, Lewis NE, Thulin CD. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. Journal of Biomolecular Techniques: JBT. 2004; 15(4):238.
Geho DH, Jones CD, Petricoin EF, Liotta LA. Nanoparticles: potential biomarker harvesters. Current Opinion in Chemical Biology. 2006; 10: 56-61. https://doi.org/10.1016/j.cbpa.2006.01.003
Luchini A, Fredolini C, Espina BH, Meani F, Reeder A, Rucker S, et al. Nanoparticle technology: addressing the fundamental roadblocks to protein biomarker discovery. Current Molecular Medicine. 2010; 10: 133-41. https://doi.org/10.2174/156652410790963268
Koka JA, Wani AH, Bhat MY, Evaluation of antifungal activity of Magnesium oxide (MgO) and Iron oxide (FeO) nanoparticles on rot causing fungi, Journal of Drug Delivery and Therapeutics. 2019; 9(2-s):173-178
Meani F, Pecorelli S, Liotta L, Petricoin EF. Clinical application of proteomics in ovarian cancer prevention and treatment. Molecular Diagnosis & Therapy. 2009; 13: 297-311. https://doi.org/10.1007/BF03256335
Longo C, Patanarut A, George T, Bishop B, Zhou W, Fredolini C, et al. Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PloS One. 2009; 4: e4763. https://doi.org/10.1371/journal.pone.0004763
Gaspari M, Ming-Cheng Cheng M, Terracciano R, Liu X, Nijdam AJ, Vaccari L, et al. Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma. Journal of Proteome Research. 2006; 5: 1261-6. https://doi.org/10.1021/pr050417+
Terracciano R, Gaspari M, Testa F, Pasqua L, Tagliaferri P, Cheng MM, et al. Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles. Proteomics. 2006; 6: 3243-50. https://doi.org/10.1002/pmic.200500614
Najam-ul-Haq M, Rainer M, Szabó Z, Vallant R, Huck CW, Bonn GK. Role of carbon nano-materials in the analysis of biological materials by laser desorption/ionization-mass spectrometry. Journal of Biochemical and Biophysical Methods. 2007; 70: 319-28. https://doi.org/10.1016/j.jbbm.2006.11.004
Xu S, Li Y, Zou H, Qiu J, Guo Z, Guo B. Carbon nanotubes as assisted matrix for laser desorption/ionization time-of-flight mass spectrometry. Analytical Chemistry. 2003; 75: 6191-5. https://doi.org/10.1021/ac0345695
Wang CH, Li J, Yao SJ, Guo YL, Xia XH. High-sensitivity matrix-assisted laser desorption/ionization Fourier transform mass spectrometry analyses of small carbohydrates and amino acids using oxidized carbon nanotubes prepared by chemical vapor deposition as matrix. Analytica Chimica Acta. 2007; 604: 158-64. https://doi.org/10.1016/j.aca.2007.10.001
Jokerst JV, Raamanathan A, Christodoulides N, Floriano PN, Pollard AA, Simmons GW, et al. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosensors & Bioelectronics. 2009; 24: 3622-9. https://doi.org/10.1016/j.bios.2009.05.026
Hung YC, Pan HA, Tai SM, Huang GS. A nanodevice for rapid modulation of proliferation, apoptosis, invasive ability, and cytoskeletal reorganization in cultured cells. Lab on a Chip. 2010; 10: 1189-98 https://doi.org/10.1039/b921354f
Popescu RC, Fufă MO, Grumezescu AM. Metal-based nanosystems for diagnosis. Rom J Morphol Embryol. 2015; 56(2):635-49.
Singh R. Nanotechnology based therapeutic application in cancer diagnosis and therapy. 3 Biotech. 2019; 9: 415. https://doi.org/10.1007/s13205-019-1940-0
Wan X, Song Y, Song N, Li J, Yang L, Li Y, et al. The preliminary study of immune superparamagnetic iron oxide nanoparticles for the detection of lung cancer in magnetic resonance imaging. Carbohydrate Research. 2016; 419: 33-40. https://doi.org/10.1016/j.carres.2015.11.003
Sherry AD, Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annual Review of Biomedical Engineering. 2008; 10: 391-411. https://doi.org/10.1146/annurev.bioeng.9.060906.151929
Kim HS, Oh SY, Joo HJ, Son KR, Song IC, Moon WK. The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR in Biomedicine. 2010; 23: 514-22. https://doi.org/10.1002/nbm.1487
Jafari A, Salouti M, Shayesteh SF, Heidari Z, Rajabi AB, Boustani K, et al. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI. Nanotechnology. 2015; 26: 075101. https://doi.org/10.1088/0957-4484/26/7/075101
Stocke NA, Meenach SA, Arnold SM, Mansour HM, Hilt JZ. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying. International Journal of Pharmaceutics. 2015; 479: 320-8. https://doi.org/10.1016/j.ijpharm.2014.12.050
Garrigue P, Tang J, Ding L, Bouhlel A, Tintaru A, Laurini E, et al. Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceedings of the National Academy of Sciences of the United States of America. 2018; 115: 11454-9. https://doi.org/10.1073/pnas.1812938115
Ji T, Zhao Y, Wang J, Zheng X, Tian Y, Zhao Y, Nie G. Tumor Fibroblast Specific Activation of a Hybrid Ferritin Nanocage‐Based Optical Probe for Tumor Microenvironment Imaging. Small. 2013; 9(14):2427-31. https://doi.org/10.1002/smll.201300600
Parungo CP, Ohnishi S, De Grand AM, Laurence RG, Soltesz EG, Colson YL, et al. In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. Annals of Surgical Oncology. 2004; 11: 1085-92. https://doi.org/10.1245/ASO.2004.03.054
Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnology. 2004; 22: 969-76.
https://doi.org/10.1038/nbt994
Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science (New York, NY). 2002; 298: 1759-62. https://doi.org/10.1126/science.1077194
Zhang Y, Yang H, An X, Wang Z, Yang X, Yu M, et al. Controlled Synthesis of Ag(2) Te@Ag(2) S Core-Shell Quantum Dots with Enhanced and Tunable Fluorescence in the Second Near-Infrared Window. Small. 2020; 16: e2001003. https://doi.org/10.1002/smll.202001003
Qureshi A, Jain PK, Shrivastava A, Jain S, Nema P, Jain H. Evaluation of antidepressant activity of aqueous and ethanolic extracts of glycyrrhiza glabra. Asian Journal of Pharmaceutical Education and Research. 2022; 11(2): 84-92.
Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100: 13549-54. https://doi.org/10.1073/pnas.2232479100
Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technology in Cancer Research & Treatment. 2004; 3: 33-40. https://doi.org/10.1177/153303460400300104
Nunes T, Pons T, Hou X, Van Do K, Caron B, Rigal M, Di Benedetto M, Palpant B, Leboeuf C, Janin A, Bousquet G. Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer. Journal of Experimental & Clinical Cancer Research. 2019; 38(1):1-3. https://doi.org/10.1186/s13046-019-1305-x
Fu N, Hu Y, Shi S, Ren S, Liu W, Su S, et al. Au nanoparticles on two-dimensional MoS(2) nanosheets as a photoanode for efficient photoelectrochemical miRNA detection. The Analyst. 2018; 143: 1705-12. https://doi.org/10.1039/C8AN00105G
Fu F, Li L, Luo Q, Li Q, Guo T, Yu M, et al. Selective and sensitive detection of lysozyme based on plasmon resonance light-scattering of hydrolyzed peptidoglycan stabilized-gold nanoparticles. The Analyst. 2018; 143: 1133-40. https://doi.org/10.1039/C7AN01570D
Vishwakarma H, Thakur K, Purohit A, Jain S, Nema P, Jain PK. A herbal approach for the treatment of kidney stone. International Journal of Medical Sciences and Pharma Research. 2022; 8(1): 1-9.
Shrivas K, Nirmalkar N, Thakur SS, Deb MK, Shinde SS, Shankar R. Sucrose capped gold nanoparticles as a plasmonic chemical sensor based on non-covalent interactions: Application for selective detection of vitamins B(1) and B(6) in brown and white rice food samples. Food Chemistry. 2018; 250: 14-21. https://doi.org/10.1016/j.foodchem.2018.01.002
Couvreur P. Polyalkylcyanoacrylates as colloidal drug carriers. Critical Reviews in Therapeutic Drug Carrier Systems. 1988; 5: 1-20.
Duncan R. The dawning era of polymer therapeutics. Nature Reviews Drug discovery. 2003; 2: 347-60. https://doi.org/10.1038/nrd1088
Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nano-scale drug delivery. Reactive and Functional Polymers. 2011; 71(3):227-34.
https://doi.org/10.1016/j.reactfunctpolym.2010.10.009
Blanco E, Bey EA, Khemtong C, Yang SG, Setti-Guthi J, Chen H, et al. Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy. Cancer Research. 2010; 70: 3896-904. https://doi.org/10.1158/0008-5472.CAN-09-3995
Tian C, Feng J, Cho HJ, Datta SS, Prud'homme RK. Adsorption and Denaturation of Structured Polymeric Nanoparticles at an Interface. Nano Letters. 2018; 18: 4854-60. https://doi.org/10.1021/acs.nanolett.8b01434
Nakanishi T, Fukushima S, Okamoto K, Suzuki M, Matsumura Y, Yokoyama M, et al. Development of the polymer micelle carrier system for doxorubicin. Journal of Controlled Release. 2001; 74: 295-302. https://doi.org/10.1016/S0168-3659(01)00341-8
Savic R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 2003; 300: 615-8. https://doi.org/10.1126/science.1078192
Jones M, Leroux J. Polymeric micelles-a new generation of colloidal drug carriers. European Journal of Pharmaceutics and Biopharmaceutics. 1999; 48: 101-11. https://doi.org/10.1016/S0939-6411(99)00039-9
Chaudhary K, Parihar S, Sharma D, A Critical Review on Nanoscience Advancement: In Treatment of Viral Infection. Journal of Drug Delivery and Therapeutics. 2021; 11(6):225-237 https://doi.org/10.22270/jddt.v11i6.5030
Nema P, Jain S, Vishwakarma H, Purohit A, Jain PK. A complete review on aromatherapy: a complementary alternative medication therapy with recent trend. International Journal of Medical Sciences and Pharma Research. 2021; 7(4): 1-7.
Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug discovery. 2008; 7: 771-82. https://doi.org/10.1038/nrd2614
Berry G, Billingham M, Alderman E, Richardson P, Torti F, Lum B, et al. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. Annals of Oncology. 1998; 9: 711-6. https://doi.org/10.1023/A:1008216430806
Ewer MS, Martin FJ, Henderson C, Shapiro CL, Benjamin RS, Gabizon AA. Cardiac safety of liposomal anthracyclines. Seminars in Oncology. 2004; 31: 161-81. https://doi.org/10.1053/j.seminoncol.2004.08.006
Singh H, Sharma T, Green Synthesis and Evaluation of Silver Nanoparticles Using Cyperus Rotundus. International Journal of Medical Sciences and Pharma Research, 2021; 7(3):1-7. https://doi.org/10.22270/ijmspr.v7i3.26
Kesharwani P, Iyer AK. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discovery Today. 2015; 20: 536-47. https://doi.org/10.1016/j.drudis.2014.12.012
Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Current Opinion in Chemical Biology. 2005; 9: 674-9. https://doi.org/10.1016/j.cbpa.2005.10.005
Brennan ME, Coleman JN, Drury A, Lahr B, Kobayashi T, Blau WJ. Nonlinear photoluminescence from van Hove singularities in multiwalled carbon nanotubes. Optics Letters. 2003; 28: 266-8. https://doi.org/10.1364/OL.28.000266
Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102: 11600-5. https://doi.org/10.1073/pnas.0502680102
Burlaka A, Lukin S, Prylutska S, Remeniak O, Prylutskyy Y, Shuba M, et al. Hyperthermic effect of multi-walled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies. Experimental Oncology. 2010; 32: 48-50.
Yu X, Gao D, Gao L, Lai J, Zhang C, Zhao Y, et al. Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes. ACS Nano. 2017; 11: 10147-58. https://doi.org/10.1021/acsnano.7b04736
Karnati KR, Wang Y. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations. Physical Chemistry Chemical Physics. 2018; 20: 9389-400. https://doi.org/10.1039/C8CP00124C
Purohit A, Jain S, Nema P, Jain DK, Vishwakarma H, Jain PK. A comprehensive review on tailoring an herbal approach for treatment of poly cystic ovarian syndrome. Asian Journal of Dental and Health Sciences. 2022; 2(1): 27-32.
Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends in Pharmacological Sciences. 2009; 30: 592-9. https://doi.org/10.1016/j.tips.2009.08.004
Bozzuto G, Molinari A. Liposomes as nanomedical devices. International Journal of Nanomedicine. 2015; 10: 975-99. https://doi.org/10.2147/IJN.S68861
Fenske DB, Cullis PR. Liposomal nanomedicines. Expert Opinion on Drug Delivery. 2008; 5: 25-44. https://doi.org/10.1517/17425247.5.1.25
Allen TM, Cullis PR. Liposomal drug del
ivery systems: from concept to clinical applications. Advanced Drug Delivery Reviews. 2013; 65: 36-48. https://doi.org/10.1016/j.addr.2012.09.037
Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine. 2006; 1: 297-315.
Fvenson S, Tomalia DA. Dendrimers in biomedical applications--reflections on the field. Advanced Drug Delivery Reviews. 2005; 57: 2106-29. https://doi.org/10.1016/j.addr.2005.09.018
Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Advanced Drug Delivery Reviews. 2012; 64:102-15. https://doi.org/10.1016/j.addr.2012.09.030
Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. Dendritic macromolecules: synthesis of starburst dendrimers. Macromolecules. 1986; 19(9):2466-8. https://doi.org/10.1021/ma00163a029
Sunil Kumar Prajapati, Vijay Kumar Tilak, Ram Chand Dhakar, Krishan Kumar Verma, Vikrant Saluja, R. Jayakumararaj, Rajeshwar Kamal Kant Arya, Manas Kumar Das, Soumya Das. Dendrimers as Drug Delivery Carriers in the Dentistry, Asian Journal of Dental and Health Sciences2021; 1(1):1-9. https://doi.org/10.22270/ajdhs.v1i1.3
Palmerston Mendes L, Pan J, Torchilin VP. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules. 2017; 22. https://doi.org/10.3390/molecules22091401
Sherje AP, Jadhav M, Dravyakar BR, Kadam D. Dendrimers: A versatile nanocarrier for drug delivery and targeting. International Journal of Pharmaceutics. 2018; 548: 707-20. https://doi.org/10.1016/j.ijpharm.2018.07.030
Wiener EC, Konda S, Shadron A, Brechbiel M, Gansow O. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Investigative Radiology. 1997; 32: 748-54 https://doi.org/10.1097/00004424-199712000-00005
Parajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, Dhakar RC, Dendrimers in drug delivery, diagnosis and therapy: basics and potential applications. Journal of Drug Delivery and Therapeutics. 2016; 6(1):67-92 https://doi.org/10.22270/jddt.v6i1.1190
Parajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, Dhakar RC, Potential application of dendrimers in drug delivery: A concise review and update. Journal of Drug Delivery and Therapeutics. 2016; 6(2):71-88 https://doi.org/10.22270/jddt.v6i2.1195
Roy R, Baek MG. Glycodendrimers: novel glycotope isosteres unmasking sugar coding. case study with T-antigen markers from breast cancer MUC1 glycoprotein. Journal of Biotechnology. 2002; 90: 291-309. https://doi.org/10.1016/S1389-0352(01)00065-4
Ekimov AI, Onushchenko AAJJL. Quantum Size Effect in Three-Dimensional Microscopic Semiconductor. Crystals. 1981; 34: 363.
Kastner MA, Klein O, Lyszczarz TM, Mankiewich PM, Shaver DC, Wind S, Abusch-Magder D, Goldhaber-Gordon DJ, Morgan NY. Artificial atoms. Research Laboratory of Electronics (RLE) at the Massachusetts Institute of Technology (MIT); 1994.
Sung SY, Su YL, Cheng W, Hu PF, Chiang CS, Chen WT, et al. Graphene Quantum Dots-Mediated Theranostic Penetrative Delivery of Drug and Photolytics in Deep Tumors by Targeted Biomimetic Nanosponges. Nano Letters. 2019; 19: 69-81. https://doi.org/10.1021/acs.nanolett.8b03249
Chen C, Peng J, Xia HS, Yang GF, Wu QS, Chen LD, et al. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials. 2009; 30: 2912-8. https://doi.org/10.1016/j.biomaterials.2009.02.010
Published
How to Cite
Issue
Section
Copyright (c) 2022 Arpana Purohit, Lakshmi Soni, Lakshmi Thakur, Jaydev Shrivastava, Khaleel Khan, Karan Shrivastava, Sameeksha Jain
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.